(Q37973611)

English

Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

scientific article published on 06 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

subthalamic nucleus

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philippe De Deurwaerdère

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Sylvia Navailles

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

6 January 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Molecular Neurobiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

45

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

173-185

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1007/s12035-011-8230-0

0 references

Prevalence, etiology, and treatment of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

The occurrence of depression in Parkinson's disease. A community-based study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Increased risk of Parkinson's disease after depression: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Rodent models of treatment-induced motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions,

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalon

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Mania following deep brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Behavioural disorders, Parkinson's disease and subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Optical deconstruction of parkinsonian neural circuitry

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Deep brain stimulation of the nucleus accumbens shell increases impulsive behavior and tissue levels of dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

High-frequency stimulation of the subthalamic nucleus inhibits the firing of juxtacellular labelled 5-HT-containing neurones

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Responses of rat substantia nigra compacta neurones to L-DOPA.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-Dopa-Induced Release of Cerebral Monoamines

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-dopa in Parkinsonism. A possible mechanism of action.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Effect of nerve activity on the in vivo release of [3H]serotonin continuously formed from l-[3H]tryptophan in the caudate nucleus of the cat

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Presynaptic control of serotonin on striatal dopamine function

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Chronic intermittent L-DOPA treatment induces changes in dopamine release

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

The selective 5-HT1A receptor antagonist WAY-100635 inhibits neuronal activity of the ventromedial prefrontal cortex in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

5-HT1B receptor binding in degenerative movement disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Low-dose clozapine improves dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Serotonin 2A receptors and visual hallucinations in Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Hallucinations and psychosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

The use of an antagonist 5-HT2a/c for depression and motor function in Parkinson' disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Pathological synaptic plasticity in the striatum: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-3,4-dihydroxyphenylalanine-induced sprouting of serotonin axon terminals: A useful biomarker for dyskinesias?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Surgical treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Dopamine and the regulation of cognition and attention

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Cognitive status of patients with Parkinson's disease and pathological gambling

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8230-0

21 January 2018

L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine (3-hydroxytyramine) and brain function

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deep-brain stimulation for Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventing levodopa-induced dyskinesias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional neurosurgery: past, present, and future.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subthalamic stimulation in Parkinson disease: a multidisciplinary approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-Dopa for Parkinsonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography of striatal serotonin transporters in Parkinson disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism of exogenous L-dopa in the brain: an immunohistochemical study of its conversion to dopamine in non-catecholaminergic cells of the rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine action and disorders of neurotransmitter balance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of deep brain stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of perturbation in monoamine metabolism by L-dopa therapy: in vivo and in vitro studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of deep brain stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency stimulation of the subthalamic nucleus increases c-fos immunoreactivity in the dorsal raphe nucleus and afferent brain regions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiologic basis of surgery for Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT(2C) receptor antagonists enhance the behavioural response to dopamine D(1) receptor agonists in the 6-hydroxydopamine-lesioned rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain dopamine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychosis of Parkinson's disease: serotonin 2A receptor inverse agonists as potential therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22222679

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-011-8230-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222679%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37973611&oldid=1411836893"